Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma

Por Reznik, Robert, Hendifar, Andrew E., Tuli, Richard
Publicado em 2014

Meta-analyses of treatment standards for pancreatic cancer

Por GONG, JUN, TULI, RICHARD, SHINDE, ARVIND, HENDIFAR, ANDREW E.
Publicado no Mol Clin Oncol (2016)

Review of systemic therapies for locally advanced and metastatic rectal cancer

Por Yaffee, Patrick, Osipov, Arsen, Tan, Carlyn, Tuli, Richard, Hendifar, Andrew
Publicado no J Gastrointest Oncol (2015)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma

Por Iriana, Sentia, Ahmed, Shahzad, Gong, Jun, Annamalai, Alagappan Anand, Tuli, Richard, Hendifar, Andrew Eugene
Publicado no Front Oncol (2016)

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide

Por Chawla, Sant P, Staddon, Arthur, Hendifar, Andrew, Messam, Conrad A, Patwardhan, Rita, Kamel, Yasser Mostafa
Publicado em 2013

Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma

Por Hendifar, Andrew, Osipov, Arsen, Khanuja, Jasleen, Nissen, Nicholas, Naziri, Jason, Yang, Wensha, Li, Quanlin, Tuli, Richard
Publicado no PLoS One (2016)

Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients

Por Yue, Yong, Osipov, Arsen, Fraass, Benedick, Sandler, Howard, Zhang, Xiao, Nissen, Nicholas, Hendifar, Andrew, Tuli, Richard
Publicado no J Gastrointest Oncol (2017)

Gender Disparities in Metastatic Colorectal Cancer Survival

Por Hendifar, Andrew, Yang, Dongyun, Lenz, Felicitas, Lurje, Georg, Pohl, Alexandra, Lenz, Cosima, Ning, Yan, Zhang, Wu, Lenz, Heinz-Josef
Publicado em 2009

A Meta-Analysis of Osteosarcoma Outcomes in the Modern Medical Era

Por Allison, Daniel C., Carney, Scott C., Ahlmann, Elke R., Hendifar, Andrew, Chawla, Sant, Fedenko, Alex, Angeles, Constance, Menendez, Lawrence R.
Publicado em 2012

Pancreatic cancer cachexia: a review of mechanisms and therapeutics

Por Tan, Carlyn R., Yaffee, Patrick M., Jamil, Laith H., Lo, Simon K., Nissen, Nicholas, Pandol, Stephen J., Tuli, Richard, Hendifar, Andrew E.
Publicado em 2014

Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity

Por Yang, Dongyun, Hendifar, Andrew, Lenz, Cosima, Togawa, Kayo, Lenz, Felicitas, Lurje, Georg, Pohl, Alexandra, Winder, Thomas, Ning, Yan, Groshen, Susan, Lenz, Heinz-Josef
Publicado em 2011

Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy

Por Osipov, Arsen, Naziri, Jason, Hendifar, Andrew, Dhall, Deepti, Rutgers, Joanne K., Chopra, Shefali, Li, Quanlin, Tighiouart, Mourad, Annamalai, Alagappan, Nissen, Nicholas N., Tuli, Richard
Publicado no J Gastrointest Oncol (2016)

Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma

Por Chawla, Sant P., Cranmer, Lee D., Van Tine, Brian A., Reed, Damon R., Okuno, Scott H., Butrynski, James E., Adkins, Douglas R., Hendifar, Andrew E., Kroll, Stew, Ganjoo, Kristen N.
Publicado no J Clin Oncol (2014)

Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas

Por Zill, Oliver A., Greene, Claire, Sebisanovic, Dragan, Siew, LaiMun, Leng, Jim, Vu, Mary, Hendifar, Andrew E., Wang, Zhen, Atreya, Chloe E., Kelley, Robin K., Van Loon, Katherine, Ko, Andrew H., Tempero, Margaret A., Bivona, Trever G., Munster, Pamela N., Talasaz, AmirAli, Collisson, Eric A.
Publicado no Cancer Discov (2015)